Idiotypic Cascades After MAb OC 125 Application
- 1 October 1993
- journal article
- research article
- Published by Mary Ann Liebert Inc in Hybridoma
- Vol. 12 (5) , 577-582
- https://doi.org/10.1089/hyb.1993.12.577
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- New monoclonal antibodies identify the glycoprotein carrying the CA 125 epitopeAmerican Journal of Obstetrics and Gynecology, 1991
- Evidence for interaction of human anti-idiotypic antibodies with CA 125 determination in a patient after radioimmunodetectionClinical Chemistry, 1990
- Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancerArchiv für Gynäkologie, 1989
- Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A.Proceedings of the National Academy of Sciences, 1989
- DEVELOPMENT OF ANTI-IDIOTYPIC ANTIBODIES AGAINST TUMOUR ANTIGENS AND AUTOANTIGENS IN OVARIAN CANCER PATIENTS TREATED INTRAPERITONEALLY WITH MOUSE MONOCLONAL ANTIBODIESThe Lancet, 1988
- Evaluation of serum CA 125 levels in the monitoring of ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1987
- Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1985
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981